HLA-C and neoplasm: The TCR in TCR-T, a dimer composed of α and β peptide chains, can specifically recognize and bind to MHC-presented intracellular and extracellular antigen fragments, thereby activating T cells to attack tumor cells (Zhao et al., 2021).